Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
5 Food varieties to Remember for Your Eating regimen for Ideal Wellbeing - 25 Worldwide Road Food varieties You Should Attempt
- 35 Great High-Mileage Electric Vehicles Of 2024
- 4Saturn's moon Titan may not have a buried ocean as long suspected, new study suggests
- 5More loons are filling Maine's lakes with their ghostlike calls
- NASA's SPHEREx telescope completes its 1st cosmic map of the entire sky and it's stunning!
- From Fledgling to Master: Self-awareness in a Side interest
- The Specialty of Compromise: Examples from Reality
- How do my eyes adjust to the dark and how long does it take?
- An 'explosion' of solo-agers are struggling with rising costs and little support: 'I'm flying without a net'
- Going with Children: Tips for Tranquil Family Get-aways
- The most effective method to Execute a Lung-Solid Eating routine After a Cellular breakdown in the lungs Finding
- Figure out How to Alter Your Volvo XC40 for Further developed Solace
- One third of Spanish pork export certificates blocked since swine fever outbreak, minister says
